Following the Thursday confirmation of Robert F. Kennedy Jr. as head of Health and Human Services, doctors weigh in on the new secretary’s plans to make America healthy again.

Photo: DAVID DEE DELGADO/AFP via Getty Images The Food and Drug Administration hasn’t approved Ozempic, Wegovy or any other weight-loss drug for obesity treatment in children under 12 ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Another busy day, so let’s get straight into the news ...

Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's ...

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

“RFK Jr. has a rare quality among public officials ... Schweikert has promoted weight-loss drugs such as Ozempic as a way to address the country’s fiscal woes. In that regard he has found ...

Kennedy signaled optimism on GLP-1 drugs like Ozempic and WeGovy for treating obesity ... questions outside the public hearings. A vote on RFK Jr.’s confirmation has not been set.

Novo Nordisk's Ozempic, Indivior's pain drug Suboxone and other medicines. The firm has a history of litigation involving the drug industry, according to its website. With RFK Jr. appointment for ...